DPharm Disruptive Innovator of the Year Announced

The partnership between Medidata Solutions and Spaulding Clinical Research is chosen as the winner of DPharm “American Idol”.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Disruptive Innovations
We applaud Spaulding and Medidata not only for bringing two novel technologies together, but also for putting ‘skin in the game’ by testing/validating the system on their expense in the clinic.

New York, New York (PRWEB) October 02, 2013

Medidata Solutions and Spaulding Clinical Research were honored with the title of Disruptive Innovator of the Year at the Dpharm Disruptive Innovations conference on September 20, 2013 for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community.

The 2nd Annual Quick Fire Disruptive Technology Presentations in an “American Idol /Shark Tank” format featured a number of innovators who were questioned and challenged by a panel of judges to determine how each technology was disruptive in advancing clinical development.

Randy Spaulding, Founder and CEO of Spaulding Clinical Research, gave a dynamic presentation alongside Glen de Vries, President of Medidata Solutions, to demonstrate how a study will integrate Spaulding’s cloud-based webECG™ Management Solution, Withings’ mHealth devices − which monitor physical activity and weight − and the Medidata Clinical Cloud™ to engage patients in their own care. Participants can relax while their data is captured at home using mHealth devices and made available to study coordinators through Spaulding and Medidata’s cloud-based technology. In addition, study participants will receive immediate feedback through the mHealth devices, which are wirelessly linked to targeted messaging for unique patient engagement.

Determining the most disruptive winner was the DPharm judging panel:

Deirdre BeVard
VP, Development Operations, Endo Pharmaceuticals

Jeff Kasher, PhD
VP, Clinical Trial: Materials, Implementation and Transformation, Eli Lilly

Andreas Koester, MD, PhD
VP, Clinical Trial Innovation & External Alliances, Janssen, Pharmaceutical Companies of Johnson & Johnson

Craig Lipset, MBA
Head of Clinical Innovation, Research & Development, Pfizer Inc.

Todd Pietri, MBA
Partner, Milestone Venture Partners

Peter Richardson, BMedSci
Global Head Clinical & Regulatory Affairs, Alcon Laboratories

Komathi Stem
Senior Director, Product Development, Innovation Lead, Genentech

Daphne Zohar
Founder, Managing Partner, PureTech Ventures

Ms. BeVard gave everyone a chuckle at the end of the presentation by remarking, “At the risk of sounding like the Paula Abdul of the group, that was awesome.”

After the winner was announced, Dr. Andreas Koester shared his rationale for picking this unique collaboration as the most disruptive presentation. “Innovation doesn't work without cooperation and is not without risk,” he said. “We applaud Spaulding and Medidata not only for bringing two novel technologies together, but also for putting ‘skin in the game’ by testing/validating the system on their expense in the clinic.”

Conference Director Valerie Bowling commented, “There were many impressive presentations, so Spaulding and Medidata Solutions must be really pleased given the stiff competition.”

The DPharm event is dedicated to disruptive thinking for the advancement of clinical development. Next year’s show is scheduled for September 10-12, 2014 at the Fairmont Copley Plaza Hotel in Boston, Massachusetts. For more information, visit http://www.theconferenceforum.org.

About Medidata Solutions
Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations. For more information, visit http://www.mdsol.com.

About Spaulding Clinical Solutions
Spaulding Clinical Research, LLC (http://www.spauldingclinical.com) a change agent in the clinical research and medical device industries, is focused on driving perpetual value for their clients through technology and process innovation that delivers speed, unprecedented quality and lower costs. Spaulding Clinical Research operates a 135-bed clinical pharmacology unit with 96, 12-lead ECG, telemetry beds in West Bend, Wisconsin, USA. The facility is paperless, using a customized Phase I Electronic Data Capture system with bi-directional interfaces to clinical lab, bedside devices and telemetry. Spaulding Biometrics provides full-service biostatistics, data management and medical writing services. As a Phase I-IV centralized cardiac safety provider, Spaulding Clinical offers project management, expert cardiologist ECG over-read and a complete suite of state-of-the-art equipment provisioning, including the Spaulding webECGTM diagnostic 12-lead ECG Management Solution with the purpose-built Spaulding Model 1000iQ Electrocardiograph.

About the DPharm Conference

Dpharm: Disruptive Innovations to Advance Clinical Trials is the only annual event focused on disruptive ideas to advance drug development. The 4th annual program will take place September 10-12, 2014 at the Fairmont Copley Plaza hotel in Boston, MA. The program is organized by Valerie Bowling, Executive Director at the Conference Forum together with an advisory committee of life science disruptive thinkers. For more information, please visit http://theconferenceforum.org/.


Contact

Follow us on: Contact's Twitter

Attachments